Velcade and haemoglobin decreased Patient Reports February 11, 2012

Velcade Side Effects Report #4776786-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2005. Female patient, 59 years of age, weighting 125.7 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: buttock pain, difficulty in walking, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, herpes zoster, loss of control of legs, rash . Velcade dosage: 2.15 MG ON DAY 1, 4, 8, 11 OF CYCLE. During the same period patient was treated with PREDNISONE, VICODIN, VALIUM, TOREDOL, FAMVIR, MORPHINE, VANCOMYCIN, NAFICILLIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4970166-3
Velcade side effect was reported by a Physician from UNITED STATES on Mar 23, 2006. Male patient was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, hypoxia, interstitial lung disease, respiratory distress, white blood cell count decreased. Velcade dosage: 2.20 MG IV BOLUS. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5329728-6
Velcade side effect was reported by a Physician from FRANCE on May 03, 2007. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, abdominal rigidity, c-reactive protein increased, chest pain , cough, disease progression, febrile neutropenia, haemoglobin decreased, histiocytosis haematophagic. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5746206-0
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, febrile neutropenia, haemoglobin decreased, histiocytosis haematophagic, leukopenia, lymphoma , pulmonary haemorrhage. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient died on 06/03/2006.


Velcade Side Effects Report #5354771-0
Velcade side effect was reported by a Physician from FRANCE on May 29, 2007. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatine increased, diarrhoea, febrile bone marrow aplasia, febrile neutropenia, haemoglobin decreased, hypocalcaemia, hypomagnesaemia, hyponatraemia, mucosal inflammation. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with BLEOMYCIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, PREDNISONE, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5424517-6
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, febrile bone marrow aplasia, febrile neutropenia, haemoglobin decreased, hypocalcaemia, hypomagnesaemia, hyponatraemia, mucosal inflammation. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with BLEOMYCIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, PREDNISONE, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5731538-2
Velcade side effect was reported by a Physician from UNITED STATES on Apr 26, 2008. Male patient, 71 years of age, weighting 131.4 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, disease progression, haemoglobin abnormal, haemoglobin decreased, hyperglycaemia, hypoalbuminaemia, hypocalcaemia, hypotension. Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 04/30/2008.

Velcade Side Effects Report #5761928-3
Velcade side effect was reported by a Physician from UNITED STATES on May 23, 2008. Male patient, 59 years of age, weighting 215.0 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, asthenia, dehydration, dizziness , haemoglobin decreased, hypophosphataemia, ileus, infrequent bowel movements, nausea . Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. During the same period patient was treated with IRINOTECAN, ATIVAN, METOPROLOL TARTRATE, MORPHINE, VITAMIN, SIMETHICONE, IMODIUM, MOUTHWASH. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5080830-6
Velcade side effect was reported by a Physician from GERMANY on Aug 05, 2005. Female patient, 69 years of age, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: bundle branch block right, chest pain , haemoglobin decreased, malignant neoplasm progression, multiple myeloma , myocardial infarction, osteolysis, tachycardia. Velcade dosage: unknown. During the same period patient was treated with PANTOZOL, NOVALGIN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5054471-0
Velcade side effect was reported by a Physician from UNITED STATES on June 29, 2006. Female patient, 68 years of age, weighting 126.1 lb, was diagnosed with ovarian cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dizziness , failure to thrive, fatigue, feeling abnormal, haematocrit decreased, haemoglobin decreased, hypomagnesaemia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; 1.00 MG/M2 INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PROTONIX, LOVENOX, TOPROL, LASIX, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5524910-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 85 years of age, weighting 134.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dehydration, diarrhoea, haematoma, haemoglobin decreased, international normalised ratio increased, muscular weakness, nausea . Velcade dosage: 1.60 MG/M2. During the same period patient was treated with GEMCITABINE, COUMADIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5574507-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2007. Female patient, 85 years of age, weighting 134.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, haematoma, haemoglobin decreased, international normalised ratio increased, muscular weakness, nausea , thrombocytopenia. Velcade dosage: 1.60 MG/M2,; 2.60 MG,. During the same period patient was treated with GEMCITABINE, COUMADIN, DIGOXIN, PRAVACHOL, TORSEMIDE, TOPROL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5411180-3
Velcade side effect was reported by a Consumer or non-health professional from FRANCE on July 27, 2007. Male patient, 62 years of age, weighting 158.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute febrile neutrophilic dermatosis, haematocrit decreased, haemoglobin decreased, red blood cell count decreased, skin injury. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5805206-2
Velcade side effect was reported by a Physician from UNITED STATES on June 26, 2008. Male patient, child 6 years of age, weighting 50.27 lb, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.04 MG, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, HEPARIN, OXYCODONE, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5812254-5
Velcade side effect was reported by a Physician from UNITED STATES on July 07, 2008. Male patient, child 6 years of age, weighting 50.27 lb, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, gastric infection, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.04 MG, UNK, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, HEPARIN, OXYCODONE, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5829707-6
Velcade side effect was reported by a Physician from UNITED STATES on July 18, 2008. Male patient, child 6 years of age, weighting 50.27 lb, was diagnosed with neuroblastoma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, catheter related infection, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.04 MG, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, HEPARIN, OXYCODONE, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4818904-4
Velcade side effect was reported by a Physician from ISRAEL on Oct 16, 2005. Female patient, 84 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood glucose increased, confusional state, haemoglobin decreased, hyponatraemia, inappropriate antidiuretic hormone secretion, oedema peripheral, white blood cell count decreased. Velcade dosage: 2.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, NEOBLOC, MICROPIRIN, LAXADIN, BONDROMIN, MONOLONG, RAMIPRIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4976249-6
Velcade side effect was reported by a Physician from AUSTRIA on Apr 05, 2006. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, febrile neutropenia, haemoglobin decreased, mucosal inflammation, platelet count decreased, protein total increased, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient died on 03/31/2006.

Velcade Side Effects Report #4998510-1
Velcade side effect was reported by a Physician from AUSTRIA on Apr 05, 2006. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatine increased, febrile neutropenia, haemoglobin decreased, mucosal inflammation, platelet count decreased, protein total increased, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient died on 03/31/2006.


Velcade Side Effects Report #5551274-5
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, haemoglobin decreased, malignant neoplasm progression, multiple myeloma , platelet count decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, BAKTAR, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #6026132-2
Velcade side effect was reported by a Physician from UNITED STATES on Dec 16, 2008. Male patient, 80 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood calcium decreased, blood sodium decreased, bone pain, cardiac failure congestive, ejection fraction decreased, haemoglobin decreased, hypotension, left ventricular dysfunction. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, OXYCODONE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #6072789-X
Velcade side effect was reported by a Physician from UNITED STATES on Jan 27, 2009. Male patient, 80 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, asthenia, blood calcium decreased, blood sodium decreased, cardiac failure congestive, haemoglobin decreased, hypotension, left ventricular dysfunction, muscular weakness. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, OXYCODONE, PERCOCET, LIPITOR, DIOVAN, ASPIRIN, LACTULOSE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #6140485-6
Velcade side effect was reported by a Physician from UNITED STATES on Mar 19, 2009. Male patient, 80 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood calcium decreased, blood sodium decreased, cardiac failure congestive, haemoglobin decreased, hypotension, left ventricular dysfunction, muscular weakness, musculoskeletal pain. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, OXYCODONE, PERCOCET, LIPITOR, DIOVAN, ASPIRIN, LACTULOSE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #4818674-X
Velcade side effect was reported by a Physician from UNITED STATES on Oct 19, 2005. Male patient, 80 years of age, weighting 190.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, back pain , body height decreased, bone marrow oedema, constipation , haemoglobin decreased, herpes zoster, insomnia. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, KYTRIL, HYDRALAZINE, PLAVIX, VYTORIN, ARANESP, ACCUPRIL, ASPIRIN. Patient recovered.


Velcade Side Effects Report #4842807-2
Velcade side effect was reported by a Physician from MEXICO on Oct 26, 2005. Male patient, 79 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemoglobin decreased, herpes zoster, intestinal obstruction, platelet count decreased. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4715642-3
Velcade side effect was reported by a Physician from GERMANY on June 29, 2005. Female patient, 78 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood sodium decreased, circulatory collapse, colitis, dehydration, gastroenteritis , gastrointestinal toxicity, haematocrit decreased, haemoglobin decreased, platelet count decreased. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with GELONIDA, AEQUAMEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4750073-1
Velcade side effect was reported by a Physician from GERMANY on Aug 05, 2005. Female patient, 78 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood immunoglobulin a decreased, blood sodium decreased, colitis, dehydration, gastroenteritis , haematocrit decreased, haemoglobin decreased, hypovolaemia, platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with GELONIDA, AEQUAMEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4747757-8
Velcade side effect was reported by a Health Professional from FRANCE on July 19, 2005. Male patient, 77 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: grand mal convulsion, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.43 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4911231-6
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 25, 2006. Male patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acinetobacter infection, aneurysm , disease recurrence, haemoglobin decreased, hyperkalaemia, klebsiella infection, metabolic acidosis, platelet count decreased, pneumonia . Velcade dosage: unknown. During the same period patient was treated with CEFTAZIDMINE PENTAHYDRATE, RUBDERIB. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5047290-2
Velcade side effect was reported by a Health Professional from SPAIN on June 21, 2006. Male patient, 76 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood glucose increased, blood sodium decreased, cardiac arrest , haematocrit decreased, haemoglobin decreased, multi-organ failure. Velcade dosage: 2.06 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, MELPHALAN, CALCIUM. Patient was hospitalized. Patient died on 11/27/2004.

Velcade Side Effects Report #5145388-1
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 23, 2006. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma , t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: duodenal ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.75 + 1.35 MG, UNK, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASTRIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5161081-3
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 08, 2006. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, duodenal ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASTRIX, ACECLOFENAC, OXYCONTIN, LASIX, DIMENHYDRINATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4666454-0
Velcade side effect was reported by a Health Professional from on May 02, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood disorder, blood pressure decreased, dizziness , haematocrit decreased, haemoglobin decreased, heart rate increased, platelet count decreased, thrombocytopenia. Velcade dosage: 2.80 MG. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #4680988-4
Velcade side effect was reported by a Health Professional from on May 17, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, dizziness , haematocrit decreased, haematotoxicity, haemoglobin decreased, thrombocytopenia. Velcade dosage: 2.80 MG. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.


Velcade Side Effects Report #4701039-9
Velcade side effect was reported by a Physician from on June 13, 2005. Male patient, 76 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemoglobin decreased, impetigo , platelet count decreased, pseudo lymphoma, white blood cell count decreased. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with SOFRASOLONE, FLUTICASONE. Patient recovered.

Velcade Side Effects Report #4932657-0
Velcade side effect was reported by a Physician from NETHERLANDS on Feb 14, 2006. Female patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: albumin urine present, c-reactive protein increased, cardiac failure, creatinine urine decreased, epilepsy , haemoglobin decreased, hypocalcaemia, pneumonia . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, TRAMADOL, FLUIMICIL, AUGMENTIN, MORPHINE, METOCLOPRAMIDE HYDROCHLORIDE, AMOXI, FRAXIPARIN. Patient died on 12/19/2005.

Velcade Side Effects Report #4944209-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure orthostatic decreased, disease progression, dizziness , haematocrit decreased, haematotoxicity, haemoglobin decreased, heart rate increased, multiple myeloma , thrombocytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #5421862-5
Velcade side effect was reported by a Physician from GERMANY on Aug 07, 2007. Male patient, 75 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: confusional state, diarrhoea, enterococcal sepsis, gastritis haemorrhagic, gastroduodenal ulcer, haemoglobin decreased, melaena, oedema peripheral. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with GRANISETRON, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6067818-3
Velcade side effect was reported by a Physician from UNITED STATES on Jan 23, 2009. Male patient, 75 years of age, weighting 224.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood chloride increased, coagulopathy, dehydration, dysstasia, gait disturbance, haemoglobin decreased, international normalised ratio increased, muscular weakness. Velcade dosage: 298 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, COUMADIN, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4832504-1
Velcade side effect was reported by a Pharmacist from UNITED STATES on Nov 03, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, haematocrit decreased, haemoglobin decreased, incorrect dose administered, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, UNK. During the same period patient was treated with WARFARIN, ATENOLOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, ALKA, COUMADIN, TYLENOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4781674-2
Velcade side effect was reported by a Physician from GERMANY on Sept 12, 2005. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, clostridium colitis, epididymitis, gamma-glutamyltransferase increased, haemoglobin decreased, nervous system disorder, somnolence, urosepsis. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DURAGESIC, RED BLOOD CELLS, CEFIXIME, PREDNIHEXAL, PANTOPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4806868-9
Velcade side effect was reported by a Physician from GERMANY on Oct 04, 2005. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, c-reactive protein increased, clostridium colitis, epididymitis, gamma-glutamyltransferase increased, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.80 MG, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, DURAGESIC, RED BLOOD CELLS, CEFIXIME, PREDNIHEXAL, PANTOPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5703848-6
Velcade side effect was reported by a Physician from CHINA on Mar 25, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematemesis, haemoglobin decreased, haemoptysis, melaena, multi-organ failure, platelet count decreased. Velcade dosage: 2.20 MG, INTRAVENOUS. Patient died on 01/01/2008.

Velcade Side Effects Report #5714409-7
Velcade side effect was reported by a Physician from CHINA on Apr 08, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematemesis, haemoglobin decreased, haemoptysis, melaena, multi-organ failure, platelet count decreased. Velcade dosage: 2.20 MG, INTRAVENOUS. Patient died on 02/01/2008.

Velcade Side Effects Report #4564672-3
Velcade side effect was reported by a Physician from on Jan 11, 2005. Female patient, 73 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, arthralgia, confusional state, fall , haemoglobin decreased, insomnia, laboratory test abnormal, platelet count decreased, pneumonia . Velcade dosage: 2.10 MG, 3/WEEK, IV BOLUS. During the same period patient was treated with MOBLOC, MAGNESIUM, CALCIUM, VIGANTOLETTEN, PANTOZOL, HYDROCORTISON, VALORON RETARD, HEPARIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4707638-2
Velcade side effect was reported by a Health Professional from FRANCE on June 16, 2005. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chills, erythroblast count increased, haemoglobin decreased, platelet count decreased, serum ferritin increased, somnolence, white blood cell count decreased. Velcade dosage: 2.60 MG 2/WEEK INTRAVENOUS. During the same period patient was treated with FLECAINE, NOCTRAN, PREVISCAN, TENORMIN, NICARDIPINE, PAROXETINE HYDROCHLORIDE. Patient recovered.

Velcade Side Effects Report #4806916-6
Velcade side effect was reported by a Physician from BELGIUM on Oct 03, 2005. Male patient, 73 years of age, weighting 178.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, anorexia, blood ph increased, dyspnoea, haematocrit decreased, haemoglobin decreased, hypoxia, malaise, oxygen saturation decreased. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, ALLOPURINOL, TIMOLOL MALEATE, TENORMIN, LITICAN, IMODIUM, FELDENE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #4603113-4
Velcade side effect was reported by a Physician from on Feb 24, 2005. Female patient, 72 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abscess limb, haemoglobin decreased, metastases to muscle, monarthritis, muscle necrosis, pain in extremity, platelet count decreased. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with HYDROMORPHONE, AMLODIPINE, ENALAPRIL MALEATE, PANTOPRAZOLE, SERTRALINE, TORSEMIDE, URAPIDIL. Patient recovered.

Velcade Side Effects Report #4627345-4
Velcade side effect was reported by a Physician from on Mar 21, 2005. Male patient, 72 years of age, weighting 158.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, cerebellar syndrome, coordination abnormal, disease progression, dizziness , haemoglobin decreased, hyponatraemia, orthostatic hypotension, pneumonia . Velcade dosage: 1.30 MG/M2, 2/WEEK; IV BOLUS. During the same period patient was treated with TAZOCIN, LANSOPRAZOLE, ADCAL, CLODRONATE DI, METFORMIN. Patient was hospitalized and became disabled. Patient died on 10/05/2004.


Velcade Side Effects Report #4814277-1
Velcade side effect was reported by a Physician from GERMANY on Oct 11, 2005. Female patient, 72 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abscess limb, arthralgia, haemoglobin decreased, monarthritis, muscle abscess, muscle necrosis, pain in extremity, platelet count decreased. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with HYDROMORPHONE, AMLODIPINE, ENALAPRIL MALEATE, PANTOPRAZOLE, SERTRALINE, TORSEMIDE, URAPIDIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5892305-2
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2008. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchitis , dysphonia, haematocrit decreased, haemoglobin decreased, neuropathy peripheral, oedema peripheral, paraesthesia, pneumonitis, somnolence. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, ALLEGRA, ASPIRIN, COUMADIN, LOPRESSOR, VITAMIN, ZANTAC, PROCARDIA. Patient recovered.

Velcade Side Effects Report #6072792-X
Velcade side effect was reported by a Physician from UNITED STATES on Jan 27, 2009. Male patient, 71 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bursitis infective, haematocrit decreased, haemoglobin decreased, immune system disorder, lymphocyte count decreased, staphylococcal infection . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ALKERAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6094781-1
Velcade side effect was reported by a Physician from UNITED STATES on Feb 18, 2009. Male patient, 71 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bursitis infective, haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, wound infection staphylococcal. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ALKERAN, PREDNISONE, SAW PALMETTO, COLACE, OXYCODONE, ASPIRIN, ACETAMINOPHEN, VITAMINS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4778807-0
Velcade side effect was reported by a Physician from UNITED KINGDOM on Sept 09, 2005. Female patient, 71 years of age, weighting 191.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, haemoglobin decreased, hypertension, platelet count decreased, retinal vein occlusion, vision blurred. Velcade dosage: 1.96 MG, INTRAVENOUS. During the same period patient was treated with TRAMADOL, PAMIDRONATE DI, TEMAZEPAM. Patient recovered.

Velcade Side Effects Report #4903401-8
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 20, 2006. Female patient, 71 years of age, weighting 191.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, bone lesion, disease progression, haemoglobin decreased, hypercalcaemia, hypertension, platelet count decreased, retinal vein occlusion, vision blurred. Velcade dosage: 1.96 MG, INTRAVENOUS. During the same period patient was treated with TRAMADOL, PAMIDRONATE DI, TEMAZEPAM. Patient died on 12/01/2005.

Velcade Side Effects Report #5011026-1
Velcade side effect was reported by a Physician from UNITED KINGDOM on May 18, 2006. Female patient, 71 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood immunoglobulin m increased, chest x-ray abnormal, disease progression, haemoglobin decreased, lower respiratory tract infection, metabolic acidosis, multi-organ failure, platelet count decreased. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient died on 04/02/2005.

Velcade Side Effects Report #5483539-X
Velcade side effect was reported by a Physician from UNITED STATES on Sept 29, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acidosis, anuria, dialysis , haematocrit decreased, haemoglobin decreased, necrotising fasciitis, platelet count decreased, pseudomonal bacteraemia, sepsis . Velcade dosage: unknown. Patient was hospitalized. Patient died on 09/29/2007.

Velcade Side Effects Report #5580116-7
Velcade side effect was reported by a Health Professional from GERMANY on Dec 17, 2007. Male patient, 70 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: gastric haemorrhage, haemoglobin decreased. Velcade dosage: 2.40 MG/KG INTRAVENOUS. During the same period patient was treated with VERGENTAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4881318-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 12, 2005. Male patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemoglobin decreased, neuropathy peripheral, platelet count decreased, pneumonia , respiratory distress. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with THALOMID, DECADRON, COUMADIN, PAXIL, ZOMETA. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5313175-7
Velcade side effect was reported by a Health Professional from POLAND on Apr 10, 2007. Female patient, 69 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood magnesium decreased, blood potassium decreased, cerebral ischaemia, coordination abnormal, diarrhoea, haemoglobin decreased, hypertension. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, CAPTOPRIL, LEVOTHYROXINE, INDAPAMIDE, SOTALOL, TIANEPTINE, KETOPROFEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4709539-2
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on June 21, 2005. Male patient, 69 years of age, weighting 169.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, haemoglobin decreased, influenza like illness, lethargy, malaise, myalgia. Velcade dosage: 1.90 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ERYTHROPOIETIN, DEXAMETHASONE, RANITIDINE, PALLADONE, VENTOLIN, BECOTIDE. Patient recovered.

Velcade Side Effects Report #4712945-3
Velcade side effect was reported by a Physician from SINGAPORE on June 24, 2005. Female patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiomegaly, haematocrit decreased, haemoglobin decreased, platelet count decreased, pleural effusion, pneumonia bacterial, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 2.20 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized. Patient died on 06/19/2005.

Velcade Side Effects Report #4740365-4
Velcade side effect was reported by a Consumer or non-health professional from SINGAPORE on July 22, 2005. Female patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacterial infection , cardiomegaly, haematocrit decreased, haemoglobin decreased, platelet count decreased, pleural effusion, pneumonia , red blood cell count decreased. Velcade dosage: 2.20 MG, 2 WEEK, INTRAVENOUS. Patient was hospitalized. Patient died on 06/19/2005.

Velcade Side Effects Report #4801315-5
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Sept 26, 2005. Male patient, 69 years of age, weighting 169.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, haemoglobin decreased, infection , influenza like illness, lethargy, malaise, myalgia, platelet count abnormal, pyrexia. Velcade dosage: 1.90 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ERYTHROPOIETIN, DEXAMETHASONE, RANITIDINE, PALLADONE, VENTOLIN, BECONASE. Patient recovered.

Velcade Side Effects Report #4830964-3
Velcade side effect was reported by a Health Professional from POLAND on Oct 28, 2005. Female patient, 69 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral ischaemia, coordination abnormal, depressed level of consciousness, diarrhoea, haemoglobin decreased, hypertension, ileus, peripheral sensory neuropathy, red blood cell count decreased. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, CAPTOPRIL, LEVOTHYROXINE, INDAPAMIDE, SOTALOL, TIANEPTINE, KETOPROFEN, RANITIDINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5034064-1
Velcade side effect was reported by a Physician from UNITED STATES on June 09, 2006. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, asthenia, blood albumin decreased, dysstasia, ecchymosis, fall , fluid overload, haemoglobin decreased, oedema peripheral. Velcade dosage: unknown. During the same period patient was treated with THALOMID, DEXAMETHASONE, ACYCLOVIR, ACETYLSALICYLIC ACID SRT, LISINOPRIL, COUMADIN, LIPITOR, VORICONAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5076297-4
Velcade side effect was reported by a Physician from AUSTRALIA on July 26, 2006. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiomyopathy , haemoglobin decreased, interstitial lung disease, platelet count decreased, pneumonia , pneumonitis. Velcade dosage: 2.20 MG. During the same period patient was treated with MORPHINE, METOCLOPRAMIDE, OXYCONTIN, ASPIRIN, OXYCODONE, ONDANSETRON, CITALOPRAM, PANTOPRAZOLE. Patient was hospitalized. Patient died on 01/25/2006.

Velcade Side Effects Report #5449764-9
Velcade side effect was reported by a Physician from UNITED STATES on Sept 10, 2007. Male patient, 68 years of age, weighting 218.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematoma, haemoglobin decreased, thrombocytopenia. Velcade dosage: 1.3MG/M2 WEEKLY FOR 4. During the same period patient was treated with ATORVASTATIN CALCIUM, ENOXAPARIN, OXYCODONE, ACETAMINOPHEN AND OXYCODONE, PREDNISONE, VALACYCLOVIR, ONDANSETRON. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5748492-X
Velcade side effect was reported by a Health Professional from UNITED STATES on May 08, 2008. Female patient, 68 years of age, weighting 209.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: apnoea, blood pressure increased, chronic obstructive pulmonary disease, condition aggravated, constipation , haemoglobin decreased, neuropathy peripheral, oxygen saturation decreased, respiratory rate increased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADVAIR DISKUS, METORPOLOL, PROZAC, PROTONIX, DILTIAZEM, CALCITROL, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5754266-6
Velcade side effect was reported by a Physician from JAPAN on May 14, 2008. Female patient, 68 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: altered state of consciousness, cardiomegaly, dysarthria, dysstasia, encephalitis viral, haemoglobin decreased, hyperviscosity syndrome, hypokinesia, malignant neoplasm progression. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ZOFRAN, LASIX, PARIET, RED BLOOD CELLS, PLATELETS. Patient died on 03/27/2008.

Velcade Side Effects Report #5786833-8
Velcade side effect was reported by a Physician from JAPAN on June 11, 2008. Female patient, 68 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: altered state of consciousness, csf protein increased, disease progression, dysarthria, dysstasia, encephalitis viral, haemoglobin decreased, haemorrhage. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ZOFRAN, LASIX, RABEPRAZOLE, RED BLOOD CELLS, PLATELETS. Patient died on 03/27/2008.

Velcade Side Effects Report #5009183-6
Velcade side effect was reported by a Physician from JAPAN on May 08, 2006. Male patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood creatine decreased, blood fibrinogen increased, blood immunoglobulin g increased, blood urea decreased, bone marrow failure, diarrhoea, haemoglobin decreased, neuropathy peripheral. Velcade dosage: unknown. During the same period patient was treated with NICARDIPINE, NITRODERM, BIOFERMIN, CLARITHROMYCIN. Patient recovered.

Velcade Side Effects Report #5148540-4
Velcade side effect was reported by a Physician from JAPAN on Oct 25, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abnormal behaviour, blood calcium decreased, blood creatinine increased, creatinine renal clearance decreased, depressed level of consciousness, haemoglobin decreased, hepatic failure, incoherent, interleukin level increased. Velcade dosage: 1.30 + 1.50 MG/M2, UNK, INTRAVENOUS - SEE IMAGE. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5678790-X
Velcade side effect was reported by a Physician from UNITED STATES on Mar 12, 2008. Female patient, 67 years of age, weighting 145.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, haematocrit decreased, haemoglobin decreased, influenza, lymphocyte count decreased, monocyte count decreased, oedema peripheral, platelet count decreased, pneumonia . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SYNTHROID, NEXIUM, TOPROL, BENICAR, ACTONEL, ALLEGRA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5704589-1
Velcade side effect was reported by a Physician from UNITED STATES on Apr 01, 2008. Female patient, 67 years of age, weighting 145.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, atelectasis, back pain , decreased appetite, fatigue, haematocrit decreased, haemoglobin decreased, oedema peripheral, platelet count decreased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SYNTHROID, NEXIUM, TOPROL, BENICAR, ACTONEL, ALLEGRA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4765658-6
Velcade side effect was reported by a Physician from AUSTRALIA on Aug 23, 2005. Male patient, 67 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased, white blood cell count increased. Velcade dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4766715-0
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 24, 2005. Male patient, 67 years of age, weighting 174.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchiolitis, chronic obstructive pulmonary disease, emphysema, fluid overload, fluid retention, haemoglobin decreased. Velcade dosage: 1.30 MG/M2. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769138-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 24, 2005. Male patient, 67 years of age, weighting 174.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, dyspnoea, fluid overload, fluid retention, haemoglobin decreased. Velcade dosage: 1.30 MG/M2. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4594065-4
Velcade side effect was reported by a Physician from on Feb 11, 2005. Female patient, 66 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatinine abnormal, blood immunoglobulin g, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Velcade dosage: 1.66 MG, INTRAVENOUS. During the same period patient was treated with LORAZEPAM, DIPYRONE, XIPAMIDE. Patient died on 07/23/2004.


Velcade Side Effects Report #4774963-9
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 05, 2005. Female patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood sodium decreased, haemoglobin decreased, hepatic function abnormal, hyperglycaemia. Velcade dosage: 2.60 + 2.00MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with AMARYL, ACTOS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4814321-1
Velcade side effect was reported by a Physician from AUSTRALIA on Oct 12, 2005. Male patient, 66 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain , blood albumin increased, blood lactate dehydrogenase increased, chest x-ray abnormal, disease recurrence, dyspnoea, haematocrit decreased, haemoglobin decreased, international normalised ratio increased. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ALLOPURINOL, FLUCONAZOLE, PERINDOPRIL, INDAPAMIDE, ACYCLOVIR, PANTOPRAZOLE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4871872-1
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 20, 2005. Male patient, 66 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain , blood albumin decreased, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, lymphocyte count decreased, macrocytosis, mean cell haemoglobin increased. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ALLOPURINOL, FLUCONAZOLE, PERINDOPRIL, INDAPAMIDE, ACYCLOVIR, PANTOPRAZOLE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5201897-8
Velcade side effect was reported by a Physician from FRANCE on Dec 20, 2006. Female patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: fungal infection , haemoglobin decreased, hyperthermia, hypoxia, influenza like illness, lung disorder, platelet count increased, productive cough, pulmonary fibrosis . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, MORPHINE SULPHATE, PARACETAMOL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5122648-1
Velcade side effect was reported by a Physician from BRAZIL on Sept 22, 2006. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, cough, fatigue, haemoglobin decreased, haemoptysis, hypotension, malaise, muscle spasms, myocardial infarction. Velcade dosage: 1.30 MG/M2. Patient died on 09/21/2006.

Velcade Side Effects Report #5255824-8
Velcade side effect was reported by a Physician from JAPAN on Feb 17, 2007. Male patient, 64 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, haematocrit decreased, haemoglobin decreased, lung disorder, platelet count decreased, sepsis . Velcade dosage: 2.30 MG, UNK, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, OXYCONTIN, ALOSENN, FOSAMAX, PREDNISOLONE, BAKTAR, ATARAX, PARIET. Patient was hospitalized. Patient died on 12/01/2005.

Velcade Side Effects Report #5597661-0
Velcade side effect was reported by a Physician from JAPAN on Jan 07, 2008. Female patient, 64 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, asthma , disease progression, haemoglobin decreased, productive cough, sinusitis , stomatitis, thrombocytopenia, upper respiratory tract infection bacterial. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, ALLOPURINOL, NAIXAN, MUCOSTA, ZOVIRAX, ZITHROMAX. Patient died on 10/25/2007.

Velcade Side Effects Report #5776740-9
Velcade side effect was reported by a Physician from JAPAN on June 05, 2008. Female patient, 64 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, asthma , bronchitis , disease progression, haemoglobin decreased, sinusitis , stomatitis, thrombocytopenia, upper respiratory tract infection bacterial. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, ALLOPURINOL, NAIXAN, MUCOSTA, ZOVIRAX, ZITHROMAX. Patient died on 10/25/2007.

Velcade Side Effects Report #5858129-7
Velcade side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, 64 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood urea increased, haemoglobin decreased, lymphocyte count decreased, pneumonia influenzal. Velcade dosage: 1.60 MG, INTRAVENOUS; 2.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, RABEPRAZOLE, LENDORM, DIFLUCAN, NAIXAN. Patient died on 11/24/2007.

Velcade Side Effects Report #5894994-5
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2008. Male patient, 64 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemoglobin decreased, hypoaesthesia, lymphocyte count decreased, pneumonia influenzal, pyrexia, renal impairment. Velcade dosage: 1.6 MG, UNK, INTRAVENOUS, 2.1 MG, UNK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PARIET, LENDORM, DIFLUCAN, UBRETID. Patient died on 11/24/2007.

Velcade Side Effects Report #5937664-7
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2008. Male patient, 64 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemoglobin decreased, hypoaesthesia, lymphocyte count decreased, multiple myeloma , pneumonia influenzal, renal impairment. Velcade dosage: 1.6 MG, INTRAVENOUS, 2.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PARIET, LENDORM, DIFLUCAN, NAIXAN. Patient died on 11/24/2007.

Velcade Side Effects Report #4771205-5
Velcade side effect was reported by a Health Professional from UNITED STATES on July 11, 2005. Male patient, 64 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, haemoglobin decreased, nausea , oral intake reduced, platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with ARSENIC TRIOXIDE, ASCORBIC ACID, MELPHALAN, PROCRIT, AREDIA, KYTRIL, NEUPORGEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4854879-X
Velcade side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 64 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dyspnoea, haematocrit decreased, haemoglobin decreased, infection , lung disorder, platelet count decreased, pneumonia , pyrexia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, OXYCONTIN, ALOSENN, FOSAMAX, PREDNISOLONE, BAKTAR, ATARAX, PARIET. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4881229-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 10, 2005. Male patient, 64 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, haemoglobin decreased, nausea , oral intake reduced, platelet count decreased. Velcade dosage: unknown. During the same period patient was treated with ARSENIC TRIOXIDE, ASCORBIC ACID, MELPHALAN, PROCRIT, AREDIA, KYTRIL, NEUPOGEN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4906583-7
Velcade side effect was reported by a Physician from JAPAN on Jan 23, 2006. Male patient, 64 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, infection , lung disorder, lung infiltration, platelet count decreased, pneumonia , white blood cell count decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, OXYCONTIN, ALOSENN, FOSAMAX, PREDNISOLONE, SULFAMETHOXAZOLE, ATARAX, RABEPRAZOLE. Patient was hospitalized. Patient died on 12/01/2005.

Velcade Side Effects Report #4975086-6
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Mar 27, 2006. Female patient, 64 years of age, weighting 174.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopneumonia, gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia, hyperkalaemia, hypoglycaemia, lethargy, neutropenia. Velcade dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, INSULIN, DEXTROSEECTION, ACTRAPID. Patient was hospitalized and became disabled. Patient died on 07/27/2004.

Velcade Side Effects Report #5037931-8
Velcade side effect was reported by a Physician from UNITED KINGDOM on June 12, 2006. Female patient, 64 years of age, weighting 174.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopneumonia, chest x-ray abnormal, gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia, hyperkalaemia, hypoglycaemia. Velcade dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, INSULIN, DEXTROSEECTION, ACTRAPID. Patient was hospitalized and became disabled. Patient died on 07/27/2004.

Velcade Side Effects Report #4607671-5
Velcade side effect was reported by a Health Professional from on Feb 25, 2005. Male patient, 63 years of age, weighting 186.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, haemoglobin decreased, supraventricular tachycardia, white blood cell count decreased. Velcade dosage: 1.4 MG, INTRAVENOUS. During the same period patient was treated with PENICILLIN V, ACYCLOVIR, MORPHINE SULPHATE, QUININE SULPHATE, OMEPRAZOLE, ERYTHROPOIETIN, PAMIDRONATE DI. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4928093-3
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Feb 08, 2006. Male patient, 63 years of age, weighting 186.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood creatinine increased, blood phosphorus increased, blood urea increased, haemoglobin decreased, joint dislocation pathological, lymphocyte count abnormal, neutrophil count abnormal, platelet count decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with PENICILLIN V, ACYCLOVIR, MORPHINE SULPHATE, QUININE SULPHATE, OMEPRAZOLE, PAMIDRONATE DI, ERYTHROPOIETIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5110858-9
Velcade side effect was reported by a Physician from UNITED STATES on Sept 07, 2006. Male patient, 62 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, dysphagia, haemoglobin decreased, herpes zoster disseminated, hyponatraemia, intervertebral disc protrusion, neutrophil count decreased, pain in extremity, platelet count decreased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, MORPHINE, RANITIDINE, REGLAN, PRILOSEC, MIRALAX, SENOKOT, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5141726-4
Velcade side effect was reported by a Physician from UNITED STATES on Oct 17, 2006. Male patient, 62 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, dysphagia, haemoglobin decreased, herpes zoster disseminated, hyponatraemia, hyporeflexia, intervertebral disc protrusion, neutrophil count abnormal. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, MORPHINE, RANITIDINE, REGLAN, PRILOSEC, MIRALAX, SENOKOT, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5880628-2
Velcade side effect was reported by a Physician from JAPAN on Sept 01, 2008. Male patient, 62 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood lactate dehydrogenase increased, cardio-respiratory arrest, disease progression, enterococcal infection, haemoglobin decreased, platelet count decreased, pyrexia, sepsis . Velcade dosage: 1.60 MG,INTRAVENOUS; 1.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN, FAMOTIDINE, VIT K CAP, ALOSENN, NAUZELIN, BIASAN. Patient died on 12/18/2007.

Velcade Side Effects Report #4893380-4
Velcade side effect was reported by a Physician from UNITED STATES on Jan 09, 2006. Male patient, 62 years of age, weighting 257.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium decreased, cardiac stress test abnormal, chronic obstructive pulmonary disease, crepitations, haematocrit decreased, haemoglobin decreased, myocardial ischaemia, po2 decreased, tachycardia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.